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Мета. Метою роботи є вивчення антигельмінтної активності та гострої токсичності препарату, що 
містить альбендазол та празиквантел у співвідношенні (1: 4) щодо збудників аскаридозу у свиней, ток-
сокарозу та дипілідіозу у собак. Ці патогени належать до класу нематодозів (аскаридозу, токсокороз) 
та цестодозів (дипілідіозу). 
Матеріали та методи. Дослідження проводили у копроскопічній лабораторії кафедри паразитології 
ХДЗВА за стандартизованим методом Фюллеборна і «Способом кількісного визначення яєць гельмінтів» 
(патент № 9265). Зразки для дослідження на собаках були отримані в КП "Центр поводження з твари-
нами". Для вивчення ступеня токсичності запропонованої комбінації альбендазолу і празиквантелу у по-
росят відбирали проби крові перед прийомом препарату та через 24 год і 72 год після початку лікування 
для проведення морфологічних і біохімічних досліджень.  
Результати. Отримані результати свідчать про наявність антигельмінтної активності досліджу-
ваного препарату по відношенню до збудників аскаридозу, токсокарозу та дипілідіозу. Показники ге-
матологічних досліджень у свиней вільних від кишкових гельмінтів до та через 24 і 72 год після при-
йому препарату знаходились у межах фізіологічної норми. Результати клінічного обстеження тварин 
обох дослідних груп показали, що поведінка тварин не змінилася (природня), прийом корму і води в но-
рмі, видимі слизові оболонки – блідо-рожевого кольору, шкірний покрив – цілісний, без пошкоджень, 
шкіра еластична. 
Висновки. Таким чином, запропонований препарат демонструє високий рівень антигельмінтної актив-
ності щодо збудників аскаридозу, токсокарозу та дипілідіозу. Ступінь його токсичності відповідає по-
казнику «малотоксичний». Отримані результати вказують на доцільність подальших досліджень 








The problem of parasitic diseases in general and 
helminthal infestations in particular, has a sharp social 
significance in the modern world. Active dissemination 
of pathogens, including those that are not typical for 
certain regions and countries, neglect of the rules of 
personal hygiene and problems in the field of health 
insurance lead to an increase in incidence of diseases 
among the population.  
 
2. Formulation of the problem in a general 
way, the relevance of the theme and its connection 
with important scientific and practical issues 
According to the World Health Organization, 
about 16 million people die each year from diseases of 
infectious and parasitic etiology [1]. In this case, children 
are the most vulnerable to this group of diseases [2, 3]. In 
children, helminthiasis of the digestive system account 
for 92.3 % of enterobiasis cases, 71.1 % of ascariasis 
cases, 61.5 % of trichocephalosis cases and 66.2 % of 
toxocarosis cases [2, 4]. 
According to the World Bank, the economic loss-
es from helminthiasis of the digestive system occupy the 
fourth place in the overall structure of diseases and inju-
ries of the planet’s population [5]. 
 
3. Analysis of recent studies and publications in 
which a solution of the problem and which draws on 
the author 
Now, the existing range of medicines for the treat-
ment of helminthiasis of the digestive system, represented 
on the pharmaceutical market of Ukraine, is presented by 
medicines of foreign production that are quite expensive 
[6]. The main side effects of such medicines are nausea, 
vomiting, pain in epigastrium, diarrhea, allergy, dizziness, 
headache, neurological disorders, impaired liver function, 
increased body temperature and drowsiness [7]. 
 
4. Allocation of unsolved parts of the general 
problem, which is dedicated to the article 
As the range of anthelminthic medicines is repre-
sented by monodrugs [8], whereas in most cases it is 
recommended to combine several active pharmaceutical 
ingredients while etiotropic treatment to achieve a quick 
and complete elimination of pathogens from the patient’s 
body [9], there were conducted the relevant studies on 
combination of albendazole and praziquantel in different 
ratios. 
 
5. Formulation of goals (tasks) of article 
We proposed the complex anthelmintic drug with 
albendazole and praziquantel in ratio (1:4) as active sub-
stances. The purpose of our work was to study the an-
thelminthic activity of this drug and study the degree of 
its acute toxicity. 
 
6. Statement of the basic material of the study 
(methods and objects) with the justification of the results 
Materials and methods. Investigation was con-
ducted in 2 stages: 
1 – in the period from April 16 to April 29, 
2018 – the experiment on pigs (n = 12) was conduct-
ed in SPC Kharkov State Zooveterinary Academy 
(KSZVA); 
2 – in the period from April 18 to May 5, 2018 – 
the experiment on dogs (n = 12) was conducted in the CP 
“Center for Animal Welfare”. 
Each animal species was divided into 2 groups: 
experimental (n = 6) and control (n=6). The animals of 
the experimental group were given the studied drug in 
the following doses:  
– for pigs: 10 mg/kg of body weight on albend-
azole and 40 mg/kg of body weight on praziquantel; 
– for dogs: 20 mg/kg of body weight on albend-
azole and 80 mg/kg of body weight on praziquantel. 
The foregoing effective doses of the drug corre-
spond to the generally accepted recommended doses of 
albendazole for anthelmintic therapy in pigs and dogs, 
respectively [10, 11]. 
Animals in the control group did not receive the 
drug.  
The anthelminthic activity of the drugs was stud-
ied in relation to pathogens of ascariasis in pigs, toxocar-
osis and dipylidiosis in dogs. These pathogens belong to 
the class of nematodosis (ascariasis, toxocarosis) and 
cestodoses (dipylidiosis), and are those often found 
among both selected species of animals and in humans. 
Infection of animals with helminthes occurred naturally 
in 3 months. The presence of pathogens in the body of 
animals was determined by a coprosopic method, in 
accordance with generally accepted rules for the diagno-
sis of each type of pathogen. 
The studied drug was administered in the thera-
peutic regime to the experimental groups of animals 
orally for 7 days. 
The effectiveness of the treatment was evaluated 
by the coprosopic method of the diagnosis of each type 
of pathogen. The proper studies were carried out in the 
coprosopic laboratory of the parasitology department of 
Kharkov State Zooveterinary Academy by the standard-
ized method of Füllbourne and the “Method for the quan-
titative determination of helminth eggs” (patent No. 
9265) [12].  
The degree of toxicity and the overall effect of the 
studied drug was evaluated on the basis of clinical exam-
ination (inspection) in both experimental groups and the 
morphological and biochemical studies of the blood 
samples of piglets (blood samples were taken before the 
beginning of the treatment and after 24 and  
72 hours after the first intake of the drug). Number of 
erythrocytes and leukocytes was determined in heparin 
stabilized blood of piglets using the Goryaev counting 
chamber; hemoglobin content was determined by hemo-
globin-cyanide method; the hematocrit was determined 
by the method of microcentrifugation according to 
Shklar. The leukogram was deduced by counting of indi-
vidual white blood cells in the smears painted according 
to Romanovsky-Gimza. 
The following parameters were determined in 
blood serum: urea level – by reaction with diacetyl-
miooxime, creatinine – by Jaffe’s colour reaction, activi-
ty of aspartate aminotransferase (AsAT) and alanine 
aminotransferase (AlAT) – by Reitman-Frenkel method 
using reagent sets of PJSC “Reagent” (Ukraine) produc-




tion according to the methods described by Kamyshnikov 
V. S. [13]. 
Data processing was carried out using methods of 
statistical analysis [14, 15]. 
7. Findings from the research and prospects of 
further development of this area 
Results and discussion. Results of coproscopic 
studies in pigs are presented in Table 1.  
As seen from Table 1, the administration of the 
studied drug provides complete elimination of ascarides 
from the body of piglets within 7 days. A follow-up study 
a week after discontinuation of therapy showed no 
recurrence of the disease. These results indicate the 
absolute effectiveness of the studied drug in relation to 
ascariasis pathogens.The results of hematological studies 
in the blood of piglets are presented in Table 2. 
 
Table 1 
Effectiveness of the studied combined anthelmintic drug in case of ascariasis in pigs (n = 12) 
Animal no. 
ІІ, eggs in 1 g of feces 
Effectiveness, % 
before treatment 
on the 7th on the 14th 
day after treatment 
Experimental group 
1 13.3 – – 
100 
2 15.7 – – 
3 12.7 – – 
4 11.0 – – 
5 18.3 – – 
6 15.3 – – 
M±m 14.4±1.1 – – 
Control group 
1 12.3 13.0 12.3 
– 
2 15.3 15.0 15.0 
3 10.3 10.3 10.0 
4 9.0 9.7 10.0 
5 12.0 11.7 12.3 
6 11.7 13.0 13.0 
M±m 11.8±0.9 12.1±0.8 12.1±0.8 
Note: p ≤ 0.05 
 
Table 2 
Results of morphological and biochemical studies of pigs blood samples free from intestinal helminthiasis, piglets 




Before administration of the 
drug 
24 h 72 h 
After administration of the drug 
No.1 No.2 No.3 No.4 No.1 No.2 No.3 No.4 No.1 No.2 No.3 No.4 
Morphological study 
Erythro-cytes, g/l 6.7 7.3 6.3 6.6 7.5 6.7 5.5 6.0 7.0 6.8 6.2 6.3 
Hemo-globin, g/l 133.7 140.8 143.4 129.8 144.5 134.5 137.1 138.6 135.3 129.3 137.1 135.3 
Leukocytes, t/l 15.8 20.6 14.2 18.5 17.3 17.6 12.0 15.5 13.5 16.0 10.2 17.2 
Hematocrit, % 36 42 34.5 38.8 30.6 34.0 36.2 38.2 38.4 38.3 36.1 39.1 
Leukoformula (%) 
Young 2 0 0 0 0 0 0 0 1 1 0 0 
Stab 13 7 5 8 5 5 8 6 9 6 8 5 
Segmanted 49 39 37 49 30 40 40 31 43 46 50 48 
Eosinophils 2 2 1 1 0 1 1 6 2 2 1 3 
Monocytes 10 4 8 5 8 3 10 2 20 10 7 10 
Basophils 0 0 2 0 0 0 0 0 0 0 0 0 




73.3 80.4 78.4 83.5 75.3 86.5 75.3 72.3 82.4 95.7 83.0 78.4 
Urea, mmol/l 3.13 2.97 2.16 2.94 1.87 1.48 1.68 1.72 3.42 2.35 2.39 3.16 
AlAT, un/l 52.5 47.4 44.8 51.5 50.9 40.2 42.9 47.4 46.7 39.2 44.8 54.7 
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As seen from Table 2, indicators of hematological 
studies in pigs free from intestinal helminthes before 24 h 
and 72 h after drug administration were within the limits 
of the physiological norm. Drug intake does not lead to 
violations of morphological indicators, changes of leu-
koformula and biochemical indicators of blood. 
The further clinical examination (inspection) of 
animals in both experimental groups showed that the 
behavior of the animals remained unchanged (natural), 
the intake of food and water was in the normal, visible 
mucous membranes were pale pink color, the skin – 
integral, no damage, elastic. 
Taking into account the results obtained, it can be 
concluded that the acute toxicity of the studied drug 
corresponds to the degree of toxicity “low toxic”, which 
is similar to the result of pure albedazole [16]. 
Results of coproscopic studies in dogs are pre-
sented in Table 3. 
 
Table 3 
Effectiveness of the studied combined anthelmintic drug when toxocarosis and dipylidiosis in dogs (n=12) 
Animal 
no. 




% Before treatment 
on the 7th on the 14th 
day after treatment 
Т D Т D Т D Т D 
Experimental group 
1 24.3 15.7 – – – – 
100 100 
2 15.3 16.7 – – – – 
3 18.0 13.0 – – – – 
4 17.7 13.7 – – – – 
5 29.0 14.7 – – – – 
6 27.0 29.3 – – – – 
M±m 21.9±2.3 17.2±2.5 – – – – 
Control group 
1 12.7 20.0 12.0 18.3 13.3 19.7 
– – 
2 15.3 18.3 16.7 16.7 16.3 19.0 
3 18.3 17.3 20.0 19.0 19.3 18.3 
4 22.3 21.0 21.0 21.7 23.0 23.0 
5 20.0 23.7 19.3 25.3 21.3 24.3 
6 15.3 18.0 16.3 16.3 15.7 17.3 
M±m 17.3±1.4 19.7±1.0 17.6±1.3 19.6±1.4 18.2±1.5 20.3±1.1 
Note: Т – toxocarosis, D – dipylidiosis, E – effectiveness; p≤0.05 
 
Results of the studied drug administration in dogs 
showed that the combination of albendazole and 
praziquantel provides complete elimination of toxoca- 
rosis and dipylidiosis pathogens from the body of dogs 
within 7 days. As in the case of ascariasis described abo- 
ve, the further investigation a week after therapy 
discontinuation showed no recurrence of the disease. 
These results indicate the absolute effectiveness of the 




The studied drug, which contains the mixture of 
albendazole and praziquantel in the ratio (1:4), proved to 
be effective in relation to pathogens of ascariasis in pigs, 
toxocarosis and dipylidiosis in dogs. Drug intake during 
7 days provides the complete elimination of helminthi-
ases with no recurrence of the disease. 
Hematological studies in pigs showed that the 
morphological indicators, leukoformula and biochemical 
indicators of blood remain in the limits of the physiologi-
cal norm 24 h and 72 h after drug intake. According to 
the results of a clinical examination (inspection) of both 
pigs and dogs at the beginning and during the experiment 
it was established that the behavior of the animals re-
mained unchanged (natural), the intake of food and water 
was in the normal, visible mucous membranes were pale 
pink color, the skin – integral, no damage, elastic. The 
obtained results allow concluding that the acute toxicity 
of the studied drug corresponds to the degree of toxicity 
“low toxic”, which is similar to the result of pure albe-
dazole. 
On the basis of the obtained results it can be con-
cluded that the proposed drug has the proved anthelmin-
thic activity with “low toxic” of degree of toxicity. 
Therefore, it is expedient to carry out the further research 
and to introduce the proposed drug into industrial pro-
duction in order to expand the existing range of anthel-
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